BTIG analyst Janine Stichter initiates coverage on Rocky Brands (NASDAQ:RCKY) with a Neutral rating.
Myriad Genetics And Illumina Announced Two Key Milestones In Strategic Partnership To Support Biopharma Clinical Trials
Under the strategic partnership, Myriad and Illumina are working together to advance comprehensive genomic profiling plus homologous recombination deficiency (HRD) testing using the globally distributed Illumina TruSight
